A comparative study in left-sided breast cancer treated with moderate deep inspiratory breath hold versus free breathing

J Egypt Natl Canc Inst. 2024 Apr 8;36(1):11. doi: 10.1186/s43046-024-00214-6.

Abstract

Background: The moderate deep inspiratory breath hold (mDIBH) is a modality famed for cardiac sparing. Prospective studies based on this are few from the eastern part of the world and India. We intend to compare the dosimetry between mDIBH and free-breathing (FB) plans.

Methods: Thirty-two locally advanced left breast cancer patients were taken up for the study. All patients received a dose of 50 Gy in 25 fractions to the chest wall/intact breast, followed by a 10-Gy boost to the lumpectomy cavity in the case of breast conservation surgery. All the patients were treated in mDIBH using active breath coordinator (ABC). The data from the two dose volume histograms were compared regarding plan quality and the doses received by the organs at risk. Paired t-test was used for data analysis.

Results: The dose received by the heart in terms of V5, V10, and V30 (4.55% vs 8.39%) and mean dose (4.73 Gy vs 6.74 Gy) were statistically significant in the ABC group than that in the FB group (all p-values < 0.001). Also, the dose received by the LADA in terms of V30 (19.32% vs 24.87%) and mean dose (32.99 Gy vs 46.65 Gy) were significantly less in the ABC group. The mean treatment time for the ABC group was 20 min, while that for the free-breathing group was 10 min.

Conclusions: Incorporating ABC-mDIBH for left-sided breast cancer radiotherapy significantly reduces the doses received by the heart, LADA, and left and right lung, with no compromise in plan quality but with an increase in treatment time.

Keywords: 3D CRT; ABC; Breast cancer; Cardiac sparing; Radiotherapy; mDIBH.

MeSH terms

  • Breast Neoplasms* / radiotherapy
  • Breath Holding
  • Female
  • Heart
  • Humans
  • Organs at Risk
  • Prospective Studies
  • Radiotherapy Dosage
  • Radiotherapy Planning, Computer-Assisted
  • Unilateral Breast Neoplasms* / radiotherapy